The changing autarky pharmaceutical R&D process: Causes and consequences of growing R&D collaboration in Japanese firms

International Journal of Technology Management

Volumn 39, Issue 1-2, 2007, Pages 33-48

  Motohashi, Kazuyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Biopharmaceuticals; National innovation system (NIS); R D collaboration

Indexed keywords

BIOTECHNOLOGY; DATA ACQUISITION; DRUG PRODUCTS; INDUSTRIAL ECONOMICS; INNOVATION; RESEARCH AND DEVELOPMENT MANAGEMENT;

BIOPHARMACEUTICALS; BIOTECHNOLOGY PROJECTS; INNOVATION POLICIES; R AND D COLLABORATION;

INDUSTRIAL RESEARCH;

EID: 34547468564     PISSN: 02675730     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJTM.2007.013439     Document Type: Article

References (18)

1. Cockburn, I. and Henderson, R. (2001) 'Publicly funded science and the productivity of the pharmaceutical industry', in Jaffe, Lerner and Stern (Eds). Innovation Policy and the Economy, Cambridge, MA: MIT Press.
2. Cockburn, I., Henderson, R., Orsenigo, L. and Pisano, G. (1999) 'Pharmaceuticals and biotechnology', US Industry in 2000, Board on Science, Technology and Economic Policy, National Research Council, Washington, DC.
3. Cohen, W., Goto, A., Nagata, R., Nelson, R. and Walsh, J. (2002) 'R&D spillovers, patents and the incentives to innovate in Japan and the United States', Research Policy, Vol. 31, pp. 1349-1367.
4. Goto, A. and Nagata, A. (1996) 'Research on innovation process by using survey data', Tokyo NISTEP (in Japanese).
5. Hayakawa, T. and Ishii, A. (2002) 'Survey of advanced biotechnology and implications toward new biopharmaceutical development (in Japanese), Iyakuhin Kenkyu, Vol. 33, No. 11, pp.689-729.
6. Hirai, H. (2002) 'Alliance of pharmaceutical firms in Europe, Japan and United States (in Japanese)', OPER Report No. 4, September.
7. Jaffe, A., Trajtenberg, M. and Henderson, R. (1993) 'Geographic localization of knowledge spillover as evidenced by patent citations', Quarterly Journal of Economics, Vol. 434, pp.578-598.
8. JPO Japan Patent Office (2001) 'Survey of Biotechnology (in Japanese)', Available at: http://www.jpo.go.jp/shiryou/index.htm.
9. Kneller, R. (2003) 'Autarkic drug discovery in Japanese pharmaceutical companies: insights into national differences in industrial innovation', Research Policy, Vol. 32, pp.1805-1827.
10. Motohashi, K. (2001) 'Insights into Japan's innovation system', Report on Japan's National Innovation System, July, Tokyo RIETI (in Japanese).
11. Motohashi, K. (2004) 'Japan's patent system and business innovation: reassessing pro-patent policies, in patents, innovation and economic performance', OECD Conference Proceedings, Paris: OECD.
12. Motohashi, K. (2005) 'University-industry collaborations in Japan: the role of new technology-based firms in transforming the national innovation system', Research Policy, Vol. 34, No. 5, June, pp.583-594.
13. Nelson (1993), National Innovation Systems, Oxford University Press" between Motohashi (2005).
14. NIKKEI Science (2001) Innovation in Medical Service in Post-Genome Era (in Japanese).
15. OECD (1999) Managing National Innovation System, Paris: OECD.
16. RIETI (2004) Report on External R&D Collaboration Survey, June, Tokyo RIETI (in Japanese).
17. Zucker, L. and Darby, M. (2001) 'Capturing technological opportunity via Japan's star scientists: evidence from Japanese firms' biotech patens and products', Journal of Technology Transfer, Vol. 26, Nos. 1/2, pp.37-58.
18. Zucker, L., Darby, M. and Armstrong, J. (1998) 'Geographically localized knowledge: spillovers or markets?' Economic Inquiry, Vol. 36, pp.65-84.